AtriCure (ATRC) Tops Q2 EPS by 19c; Offers Guidance
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $31.79 +6.93%
EPS Growth %: +92.3%
Financial Fact:
Loss from operations: -6.29M
Today's EPS Names:
CRMT, More
EPS Growth %: +92.3%
Financial Fact:
Loss from operations: -6.29M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q2 EPS of ($0.11), $0.19 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $100.9 million versus the consensus estimate of $97.55 million.
GUIDANCE:
AtriCure sees FY2023 EPS of $0.92-$0.94, versus the consensus of ($1.09). AtriCure sees FY2023 revenue of $392-395 million, versus the consensus of $388.4 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Pembina joins proposed 1M bbl/day Alberta-to-coast pipeline plan
- AeroVironment (AVAV) Tops Q4 EPS by 36c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
